跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 223 条关于
“FUCASO”
全部
223
临床试验
196
药物
11
机构
5
资讯
11
去年
IASO Biotherapeutics Reports Sustained 36-Month Efficacy Data for Fucaso CAR-T Therapy in Multiple Myeloma
10个月前
IASO Bio Partners with GC Cell to Bring First Fully Human BCMA CAR-T Therapy to South Korea
去年
Equecabtagene Autoleucel Shows High Efficacy in Relapsed/Refractory Multiple Myeloma
去年
IASO Bio's CAR-T Therapy, Equecabtagene Autoleucel, Advances in Hong Kong and Singapore for Multiple Myeloma
8个月前
Adimab Reports 11 New Clinical Programs in 2025, Reaching 89 Total Programs with Six Approved Therapies
去年
Optimal Lymphodepletion Improves Outcomes with Equecabtagene Autoleucel in Multiple Myeloma
去年
CAR-T Cell Therapy Funding Surges to $141.2 Billion as Industry Expands Globally
前天
FDA Clears IND for IASO208, First China-Originated In Vivo CAR-T to Enter US Clinic
去年
CAR-T Cell Therapy Industry Surges to $141.2 Billion in Funding as Clinical Success Drives Investment
3年前
World-First Gene Therapy Trial Offers Hope for Young Boys with Duchenne Muscular Dystrophy
第 1 页,共 2 页
上一页
下一页